ScholarIQanswers from OpenAlex

Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence

PaperCitations, authors & open-access status

Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence have?

ScholarIQcitation count

Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence has 70 citations in the OpenAlex counts ScholarIQ stores.

When was Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence published?

ScholarIQyear

Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence has 2020 year in the ScholarIQ index.

What is the open-access status of Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence?

ScholarIQoa status

Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence has hybrid oa status in the ScholarIQ index.

What is the DOI of Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence?

ScholarIQdoi

The DOI for Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence is on the source record.

What is the PMID of Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence?

ScholarIQpmid

The PMID for Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence is on the source record.

What is the OpenAlex record for Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence?

ScholarIQopenalex

The OpenAlex for Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial